Thiel Capital

Thiel Capital is a company that specializes in investment management services.

Business Model:

Revenue: $16M

Employees: 51-200

Rankings

Detailed Thiel Capital Information

Geographic Data

Thiel Capital headquarters map

Address: 1 Letterman Dr Ste 400

City: San Francisco

State: CA

Zip: 94129

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

3,936,609Website Global Rank

3,070Website Monthly Traffic

Twitter Followers

Description

Thiel Capital is an investment firm founded by Peter Thiel. Located in the Presidio of San Francisco, Thiel Capital provides strategic and operational support for Peter’s many investment initiatives and entrepreneurial endeavors. Related organizations include Clarium, Founders Fund, Mithril, Valar Ventures, and The Thiel Foundation.

Contact Phone:
+14154411460

Contact Email:

Announced Date Company Transaction Money Raised
11/2020 ATAI Life Sciences Series C 0
8/2022 28 by Evie Seed Round 0
3/2021 ATAI Life Sciences Series D 0
2/2020 EnClear Therapies Series A 0
3/2019 EnClear Therapies Seed Round 2M
2/2022 Regent Equity 18M
7/2018 Compass Therapeutics, Inc. Series A 0
10/2022 Alloy Therapeutics Series D 42M
4/2020 ATAI Life Sciences Convertible Note 25M
12/2019 Chemomab Series C 20M
7/2020 Compass Therapeutics, Inc. Venture Round 0
5/2021 Bullish Global Venture Round 300M
11/2017 Immunochina Series B 7.5M
8/2018 Spark Neuro Series A 13.5M
9/2022 Vienna Hypertext Seed Round -
1/2018 Invicta Medical Series B 0
7/2016 Invicta Medical Series A 0
10/2017 3T Biosciences Seed Round 12M
7/2017 Compass Therapeutics, Inc. Series A -
5/2018 Terminal Series A 10M
7/2017 Angiex Series A 3M
1/2020 Advano Series A 18.5M
12/2020 Rational Vaccines Series A 10M
11/2021 Mynaric Post-IPO Equity 0
7/2022 Inflection Points Seed Round 0
8/2020 Ready Seed Round 1.2M
6/2021 Ex-human Pre Seed Round 550k
4/2021 Angiex Series B 25M
7/2022 Inflection Points Seed Round 0
2/2022 Regent Venture Round 0
11/2021 Mynaric Post-IPO Equity 0
6/2021 Ex-human Pre Seed Round 0
5/2021 Bullish Global Venture Round 0
4/2021 Angiex Series B 0
3/2021 ATAI Life Sciences Series D 0
12/2020 Rational Vaccines Series A 0
11/2020 ATAI Life Sciences Series C 0
8/2020 Ready Seed Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research